Observational Study for MACHD Registry
This observational study is looking for 50 healthy adults to help compare information for the Mayo Clinic Adult Congenital Heart Disease (MACHD) Registry. The study is not testing any specific intervention or drug. Instead, it aims to understand pulmonary vascular reserve (how well your lung blood vessels can handle changes in blood flow) at the beginning of the study. You might be able to join if you are 18 or older, have a BMI (Body Mass Index) of 30 or less, healthy blood pressure, good kidney function (eGFR > 30), and can have an MRI. We are currently unsure of the study's recruitment status.
- Study design
- This is an observational study aiming to enroll 50 participants. It is designed to gather information rather than test a specific treatment.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Pulmonary vascular reserve is measured at Baseline, but no further follow-up is specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
A Study of Invasive Hemodynamic for MACHD Registry
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Alexander Egbe, MBBS, MPH · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Pulmonary vascular reserveBaseline
The slope of mean pulmonary artery pressure / cardiac output (mPAP/CO)